Investments (#)
Investments (USD)
Transactions
Recent transactions in the sector
| Company | Country | Funding round | Date | |
|---|---|---|---|---|
|
Judo Bio Inc Developer of oligonucleotide medicines delivered to the kidney. |
United States | Series A USD 100,000,000 (USD 100,000,000) |
7 Oct 2024 |
|
Genomics Medicine Ireland Ltd Dublin-based life sciences startup. |
Ireland | Series A USD 40,000,000 (USD 40,000,000) |
26 Oct 2016 |
|
Blend Therapeutics Inc Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. |
United States | Series B USD 21,000,000 (USD 21,000,000) |
7 Jan 2015 |
|
|
Blend Therapeutics Inc Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. |
United States | Series A |
6 Jan 2012 |
|
Limula SA |
Switzerland | N/A |
|
|
|
Limula SA |
Switzerland | N/A |
|
|
|
Limula SA |
Switzerland | N/A |
|
|
Prokarium Ltd Oral vaccine delivery platform. |
N/A |
||
|
|
Limula SA |
Switzerland | N/A |
|
|
|
Limula SA |
Switzerland | N/A |
|
|
|
Limula SA |
Switzerland | N/A |
Companies
Best funded companies in the sector
Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy.
Biotech company developing novel therapies for lung diseases and organ manufacturing, focusing on rare diseases and transplantable organ availability.
Business Classification
Parent business classification group
Healthcare